In our ongoing studies of trimethoprim resistance (Tmpr) in day-care centers (DCC), we have shown a high rate of fecal colonization with Tmpr Escherichia coli and, using total plasmid content analysis, have shown that this is due to a diversity of strains. In the present study, we analyzed 367 highly Tmpr (MIC, >2,000 pg/ml)
found to have this new gene, 74 of which were in one DCC. The DNA sequence of this gene was determined, and the predicted amino acid sequence was shown to have between 32% and 39%o identity with the amino acid sequences for types I, III, V, VI, and VII and the partial sequence of type IV and -26% identity with types IX and X DHFR. This confirms the uniqueness of this gene, which has tentatively been named dhfrxii, and its translation product, DHFR type XII.
Trimethoprim (TMP) is a widely used antimicrobial agent. Following the introduction of TMP and TMP-sulfamethoxazole (SXT), TMP-resistant bacterial pathogens emerged as a clinical problem. The emergence of high levels of TMP and SXT resistance among Escherichia coli isolates from stool and urine is well reported in the literature, particularly in developing countries and in day-care centers (DCC) (15, 17, 18, 21, 22) . In the United States, we have found that children in DCC caring for large numbers of diapered children have much higher rates of resistance (48% with Tmpr E. coli) than children in smaller DCC (17%), children not in DCC (6%), or healthy adults (8%) (21) . The present study was designed to evaluate the genetic diversity of Tmpr among fecal E. coli isolates from children attending DCC in Houston, Tex.
MATERIALS AND METHODS
The DCC were enrolled in prospective studies of diarrhea and were selected for the current 5-month study from a group of 12 DCC (no. 1 through 12) that had been previously studied. Written informed consent from each DCC director and permission from the parents of the enrolled children were obtained. This study was approved by the Committee for the Protection of Human Subjects of the University of Texas Medical School at Houston (21) .
Sample collection, processing, and media. Fecal samples from children enrolled in four DCC were collected in plastic containers and transported to the laboratory in styrofoam coolers for same-day plating on selective agar media by two * Corresponding author.
methods. (i)
The dilution method consisted of the following. About 1.5 mg of each stool specimen was suspended in 1.5 ml of 0.9% NaCl. After vortexing, a loopful (-1.5 RI) was streaked for single-colony isolation onto PW agar (32) containing 50 pg of TMP per ml, MacConkey agar containing 50 ,ug of TMP per ml, and PW agar with no drug. (ii) The direct streak method consisted of the following. Approximately 1.5 mg of each stool specimen was also streaked directly onto the media mentioned above. All inoculated plates were incubated at 37°C for 18 to 24 h. When available, five E. coli-like lactose-fermenting colonies and two non-lactosefermenting colonies were picked from PW agar containing TMP plates (50 ,ug/ml) and saved in peptone stabs for further studies; non-lactose fermenters were included because our previous work had identified a number of Tmpr E. coli isolates as being non-lactose fermenters.
Plasmid profiles, organism identification, susceptibility testing, and colony lysates. Over 900 Tmpr colonies were collected for plasmid pattern analysis by the lysate method of Kado and Liu (13) . Those colonies showing plasmid patterns distinct from each other were identified by the API-20E system (Analytical Products, Plainview, N.Y.). Plasmid patterns that were the same except for one or two (when more than five total plasmids were present) plasmids were considered to be the same pattern and not distinct patterns; this interpretation might underestimate the number of different patterns and thus the number of distinct strains. Susceptibility to TMP, sulfisoxazole (SU), SXT, ampicillin (AMP), cephalothin (CEP), chloramphenicol (CHL), tetracycline (TE), streptomycin (STR), and gentamicin (GM) was determined by the disk diffusion method with Mueller-Hinton NEW TMP RESISTANCE GENE IN DAY-CARE CENTERS A total of 367 highly Tmpr colonies were inoculated onto MacConkey agar plates with a Steers replicator and were incubated overnight at 37°C. Colony lysates were made with Whatman 541 paper according to the method described by Maas (14) . During the first part of the study, colony lysates were prepared only from Tmpr isolates which had been shown to have distinct plasmid patterns; during the latter part of the study, colony lysates were prepared prior to plasmid pattern detection and represented five lactose-fermenting and two non-lactose-fermenting Tmpr isolates (when present) per specimen. Results are reported only for isolates subsequently shown to be E. coli.
DNA labelling and hybridization. The type I dihydrofolate reductase (DHFR) probe was the 500-bp HpaI fragment of plasmid pFE872 (8) provided by Mary Fling. The type II probe (provided by Susan Lester) was a PflMI-SfaNI fragment isolated from the 850-bp EcoRI fragment of p700 (originally from R67) (9); this fragment had been blunt ended and cloned into the SmaI site of pUC19 and was regenerated with EcoRI-BamHI double digestion. The type III DHFR probe was an 855-bp EcoRI-HindIII fragment of pFE1242 (7) (M. Fling). The type V probe was a 489-bp KprnI-BamHI fragment of plasmid pLK022 (26) , and the type VII probe was a 314-bp EcoRV fragment of pLK0221A (both provided by Ola Skold). The probe for the new type XII gene was a 100-bp AluI fragment (see Fig. 3 ). All DNA probes were purified from low-gelling-temperature agarose with GENE-CLEAN (Bio 101, Inc., La Jolla, Calif.) and labelled by random priming with [32P]dCTP (5, 6) . Hybridization was performed under stringent conditions (50% formamide and 2x SSC [lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate] at 42°C for 18 h), and the colony lysate filters were washed four times by using 2x SSC at room temperature with slow shaking (31) . The agarose gels were alkali blotted to transfer restriction digestion DNA fragments onto Hybond-N membranes according to the instructions of the manufacturer (Amersham, Arlington Heights, Ill.).
Mating and transconjugant selection. Mating experiments (16) were performed with E. coli C600 (nalidixic acid and rifampin resistant) as the recipient strain and Mueller-Hinton agar supplemented with TMP (20 ,ug/ml) and nalidixic acid (50 p,g/ml) for selection.
Cloning and subcloning of plasmid DNA. Wild-type plasmid DNA was collected by the method of Currier and Nester (4), digested with restriction enzymes, and ligated into vectors already cut with the same enzyme. In some cases, specific bands were excised from the low-gelling-temperature agarose and were used for ligation with the vector. The vectors pACYC184, pUC18, and pUC19 were used as the cloning vehicles. Ligations were followed by transformation into competent cells. Selections were made on MuellerHinton agar plus TMP (50 ,ug/ml) for Tmpr clones and Luria-Bertani agar plus AMP (50 ,ug/ml) with isopropyl-p-Dthiogalactopyranoside (20 ,ul; 100 mM) and X-Gal (5-bromo-4-chloro-3-indolyl-13-D-galactopyranoside) (50 ,ul; 2%) for TMP-susceptible clones. The restriction endonucleases, T4 DNA ligase, and HB101-competent E. coli cells were purchased from Bethesda Research Laboratories (Gaithersburg, Md.), SURE cells were purchased from Stratagene (La Jolla, Calif.), and they were used according to the manufacturer's instructions.
DNA sequencing. DNA sequencing was performed by the chain termination method as described by Toneguzzo et al. (29) with the Sequenase sequencing kit and the M13 Sequencing Primer (-40) from U.S. Biochemicals Corp., Cleveland, Ohio, and the M13 Reverse Sequence Primer from Pharmacia LKB Biotechnology, Piscataway, N.J. The insert contained in pBEM155 was sequenced in both directions. The upstream region (to the right of the NdeI site in Fig. 3 ) was sequenced in only one direction. Sequence analysis was performed with MacVector (IBI, New Haven, Conn.) and the University of Wisconsin Genetics Computer Group software package on a VAX/VMS.
Nucleotide sequence accession number. The accession number M84522 has been assigned by GenBank.
RESULTS
Plasmid profile studies. Over 900 Tmpr isolates collected over a 5-month period from children in four DCC were analyzed by gel electrophoresis to determine their plasmid profiles. Among the 26 children in DCC no. 4, there were 22 distinct plasmid pattern groups, which we interpret as indicating 22 distinct strains (Table 1) ; these were all identified as E. coli. The representative plasmid patterns are shown in Fig. 1 and 2 . The plasmid patterns designated 01-00 and 11-00 seen in Fig. 1 , lanes a and b, respectively, were found to be the two most common patterns in DCC no. 4 and were found repetitively in this DCC throughout the 5 months of the study. Both plasmid patterns shared common antibiotic resistance to TMP, SU, SXT, AMP, CEP, and STR, and isolates with pattern 11-00 also had resistance to TE. In the other large DCC (no. 5), there were 35 distinct plasmid patterns, all representing E. coli isolates. Representative plasmid patterns can be seen in Fig. 2 . Two patterns, 08-00 and 11-99, shown in Fig. 2 , lanes f and o, were found to be the most common patterns in DCC no. 5, and the colonies bearing these patterns were non-lactose-fermenting E. coli isolates. Isolates with pattern 11-99 showed resistance to CHL, TE, and AMP, as well as to TMP, SU, SXT, and STR; the latter resistance pattern was also observed in pattern 08-00 (Table 1 ). In the small DCC (no. 1 and 2), 16 (Fig. 2, lane f) was able to transfer resistance (data not shown), while the other three predominant strains (11-99, 11-00, and 01-00) were not able to transfer resistance.
Cloning and subcloning of plasmid DNA. One Tmpr E. coli isolate which had a transferable plasmid encoding high-level Tmpr and which did not hybridize with any of the DHFR DNA probes tested, even under conditions of low stringency, was selected for further study. Initial cloning with BamHI yielded Tmpr recombinants with a 7.6-kb insert. A 6.5-kb EcoRV fragment was subcloned from this clone into the SmaI site of pUC18 to generate pBEM151 (Fig. 3) Fig. 3, pBEM155 , containing an -500-bp NdeI-HincII fragment, was the smallest clone which expressed high-level TMP resistance. The lack of resistance in clones pBEM154 and pBEM165 suggests that both ends of pBEM155 are essential for the expression of TMP resistance. A 100-bp AluI fragment from pBEM155 was then cloned into the HincII site of pUC18, and the resultant plasmid was designated pBEM164 (Fig. 3) Fig. 4 , which is reversed relative to the inserts in Fig. 3 Figure 5 shows the amino acid sequence deduced from the DNA sequence aligned by the GAP program of the Genetics Computer Group package to the amino acid sequences of several well-characterized DHFRs (7, 8, 23, 24) . The similarity (based on conserved amino acid changes) and identity, respectively, of the new protein's sequence to the sequences of these other DHFRs were 56% and 32% for type I, 60% and 35% for type III from S. typhimurium, 59% and 39% for type V, and 57% and 36% for the E. coli K-12 chromosomal DHFR. The amino acid residues previously shown to be identical in the DHFRs from diverse species (7, 30) were also present in this sequence and are marked with an asterisk. The type II DHFRs, which do not share these amino acids, had no significant homology to the new DHFR. Table 2 shows the relationships of the DHFRs aligned in Fig. 5 to the DHFR of Streptococcus (Enterococcus) faecium, a plasmid-encoded Tmpr DHFR from S. aureus (both obtained through GenBank), the recently published sequence of the type VI DHFR from Proteus mirabilis (33) , and the unpublished sequence for DHFR type VII (obtained from Ola Skold) (25) . The new protein was also found to have 46% similarity and 26% identity with the recently reported type X DHFR (20) and 46% similarity and 27% identity with the type IX DHFR (12) . Compared with the N-terminal amino acid sequence of the type IV protein (28), the new sequence had 61% similarity and 33% identity in this region. The N-terminal amino acid region reported from a plasmid-encoded DHFR from Shigella sonnei (27) had 57% similarity and 35% identity with this part of our new sequence; the S. sonnei protein has been referred to as type IlIb (3) but has only 50% similarity and 39% identity with the original type III DHFR from S. typhimurium (7, 27 ) and, thus, should probably not be considered a variant of type III.
DISCUSSION
Considerable attention has been given to antibiotic resistance found among pathogenic strains of bacteria causing disease in humans, animals, and plants. However, less attention has been given to the prevalence of these resistance genes in the fecal flora of humans at large, which may be a harbinger of resistance in strains causing infections. In this and our earlier studies, TMP resistance has been used to investigate the resistance of fecal flora in the pediatric age group. As before (22) , we found a diversity of plasmids III , and V DHFRs and the chromosomal (chrom) DHFR from E. coli K-12. Twenty-six amino acids were identical in all five of these proteins (shaded residues); the 12 amino acid residues marked with an asterisk had been previously shown to be identical in the DHFRs from diverse species (7, 30 The findings in the present study are significant not only because they again illustrate the diversity of strains colonizing diapered children in DCC settings with Tmpr E. coli but also because we have documented the existence of a new TMP resistance gene encoding high-level TMP resistance. A number of DHFRs which confer high-level resistance have been described, including types I, V, VI, and VII (Table 2) and the unrelated type II (1, 2, 10, 11, 24, 25, 33) . The newly described type X DHFR confers a MIC of 500 ,ug/ml (20 
